Check out our news archive below to learn more about what’s happening in Duke Psychiatry & Behavioral Sciences!
Blue Devil of the Week: Creating an Inclusive Climate for those Facing Trauma
Whether Duke Psychiatry's Angela Tunno, PhD, MS, is working with young patients at Duke or helping community-level systems serve trauma survivors with the Center for Child & Family Health, Dr. Tunno works to help children and families find healing. In recognition of her excellent and impactful work, she was named Blue Devil of the Week by Working@Duke this week.
Developing & Testing an Innovative Pain Management Alternative to Opioids
Chronic pain is one of the most common reasons adults in the U.S. seek medical care. Opiates are often used as a pharmacological intervention, but they present a risk of substance use disorder. In an effort to develop an alternative form of treatment, Duke Psychiatry's Eric Elbogen, PhD, and his team turned to “neurofeedback,” or electroencephalograph (EEG) biofeedback treatment.
The Rich Nonprofits Get Richer: Centering Psychiatric Grant Funding at the Margins
Community psychiatrists serve multiple institutional roles, and at times these roles may include the review of grant proposals from nonprofit organizations. In this column published in "Psychiatric Services," the authors, including Duke Psychiatry's Marvin Swartz, MD, argue that privilege and social capital can easily become concentrated among a small group of centralized model organizations and influence the grant review process. By applying a structural lens to this problem, funding entities can identify approaches that more effectively promote equity throughout the grant life cycle.
Carla Wall Recognized as Outstanding Postdoc
Carla Wall, PhD, a postdoctoral associate and an alumna of the Duke Psychiatry Clinical Psychology Doctoral Internship, was selected as one of two 2022 Outstanding Postdocs at Duke. She was nominated by her faculty mentor, Jill Howard, PhD, as well as other research team members.
Dzirasa Wins Prestigious NIH Pioneer Award to Develop New Way To Fine-Tune Brain Circuits
The $3.5 million award will adapt a cell-linker protein in humans that improves crosstalk between brain regions in hopes of rewiring circuits that go awry in psychiatric disorders. The NIH has recognized Dzirasa as one of just eight scholars for the 2022 Director’s Pioneer Award, which specifically funds promising and often paradigm-shifting projects by exceptional researchers.
Three Ways to Avoid Getting Overcommitted
Several Duke experts, including Jane Gagliardi, MD, MHS, professor of psychiatry and behavioral sciences, share some strategies for balancing ambitions with available time and energy.
Strong Duke Showing at the AMP Annual Meeting
Duke’s Internal Medicine-Psychiatry (Med-Psych) program had a strong showing at the 2022 Association of Medicine and Psychiatry (AMP) Annual Meeting in Atlanta, GA, on September 29 to October 1.
Scientists Create Non-Psychedelic Compound with Same Anti-depressant Effect
Published in Nature, this research in animal models show it’s possible to create a compound that hits the same exact target as psychedelic drugs hit – the 5-HT2A serotonin receptors on the surface of specific neurons – but does not cause the same psychedelic effects when given to mice. Duke Psychiatry's William Wetsel, PhD, was a senior author on the paper.
Large Survey Identifies Toll of Pandemic on Health Care Worker Exhaustion
Duke Psychiatry's Bryan Sexton, PhD, led a study involving more than 30,000 health care workers to track the emotional impact of the pandemic. The researchers found increases in emotional exhaustion from about 32% in 2019, before COVID hit, to 40% by January 2022. The study was published in JAMA Network Open on Sept. 21.
Joseph McClernon Named Interim Co-Director for Duke CTSA Team Science Core
Joseph McClernon, PhD, Co-Director of the CTSI’s Integration and Strategic Partnerships Pillar, has been named the Interim Co-Director for the Duke CTSA Team Science Core. Dr. McClernon is a professor in Psychiatry and Behavioral Sciences.